Losartan Potassium Tablet, Film Coated
Product Images NDC 0615-7958

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 0615-7958). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Losartan (Losartan Potassium Cadila For Zydus 1)

Chemical structure of the active ingredient Losartan Potassium, illustrating its molecular arrangement including chlorine, potassium ion, and characteristic ring structures.*

FDA Label Image

Structured Formula For Losartan (Losartan Potassium Cadila For Zydus 2)

A line graph comparing the percentage of patients with a primary endpoint over study months for Atenolol (dashed line) and Losartan Potassium (solid line). The x-axis represents study months from 0 to 66, and the y-axis shows the percentage of patients from 0 to 16%. Annotations indicate an adjusted risk reduction of 13% with a p-value of 0.021 for Losartan Potassium versus Atenolol.*

FDA Label Image

Structured Formula For Losartan (Losartan Potassium Cadila For Zydus 3)

A line graph showing the percentage of patients with fatal or non-fatal stroke over study months, comparing Losartan Potassium (solid line) and Atenolol (dashed line). The graph indicates adjusted risk reduction of 25% with Losartan Potassium, with a p-value of 0.001, across a study duration of up to 66 months.*

FDA Label Image

Structured Formula For Losartan (Losartan Potassium Cadila For Zydus 4)

A forest plot comparing hazard ratios with 95% confidence intervals for primary composite and stroke (fatal/non-fatal) events between Losartan-K and Atenolol across various patient subgroups including age, gender, race, isolated systolic hypertension (ISH), diabetes status, and history of cardiovascular disease (CVD). The plot displays event rates and hazard ratios indicating which treatment favors better outcomes in each category.*

FDA Label Image

Structure Product Formula For Losartan (Losartan Potassium Cadila For Zydus 5)

A line graph comparing the percentage of patients with an event over 48 months for Losartan Potassium Tablet versus placebo. The graph shows cumulative risk reduction of 16.1% with Losartan Potassium, with time in months on the x-axis and percentage of patients on the y-axis.*

FDA Label Image

Losartan Potassium 25mg Bingo Card Label (Losartan Potassium Cadila For Zydus 6)

Losartan Potassium Tabs USP 50 mg film-coated tablets packaging label. The label includes dosage strength of 50 mg, quantity of 30 tablets, lot number, and expiration date fields. It is manufactured by Cadila for Zydus and packaged by Vangard Labs, Glasgow, KY. The label also contains multiple barcode labels for individual tablet tracking and storage instructions at controlled room temperature (20°-25°C). The label is marked for institutional use only and includes a protective light resistance warning.*

FDA Label Image

Losartan Potassium Tabs 50mg Bingo Card Label (Losartan Potassium Cadila For Zydus 7)

Packaging label sheet for Losartan Potassium tablets USP 50 mg by NCS HealthCare of KY, LLC dba Vangard Labs. The top portion shows multiple repeating barcode labels with the product name, strength, and manufacturer details. The bottom part displays a full bottle label indicating the product name, strength, quantity (30 tablets), storage instructions, and manufacturer and repackager information, including Cadila and Vangard Labs.*

FDA Label Image

Losartan Potassium 50mg Tabs Unit Dose Label (Losartan Potassium Cadila For Zydus 8)

Losartan Potassium Tabs USP 25 mg film-coated tablets labeling sheet. The label includes barcode, lot number 7958, and space for expiration date. It is marked for institutional use with multiple smaller labels featuring product name, strength, lot number, and barcode. Labeled by NCS HealthCare of KY, LLC dba Vangard Labs, Glasgow, KY, with manufacturing by Cadila for Zydus. Storage instructions advise keeping at controlled room temperature and protecting from light.*

FDA Label Image

Losartan Potassium Tabs Usp 100mg Bingo Label (Losartan Potassium Cadila For Zydus 9)

Losartan Potassium Tabs USP 100 mg film-coated tablets packaging label. The label includes the drug name, strength (100 mg), a barcode, lot number, and expiration date fields. It specifies the product is Rx only and packaged by Vangard Labs, Glasgow, KY for Zydus. It also contains repeated smaller barcoded labels for institutional use only, with storage instructions and a dosing insert reference.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.